Einsele, Hermann

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 9.

Journal Article

Phelan, Rachel; Im, Annie; Hunter, Rebecca L; Inamoto, Yoshihiro; Lupo-Stanghellini, Maria Teresa; Rovó, Alicia; Badawy, Sherif M; Burns, Linda; Eissa, Hesham; Murthy, Hemant S; Prasad, Pinki; Sharma, Akshay; Suelzer, Elizabeth; Agrawal, Vaibhav; Aljurf, Mahmoud; Baker, Karen; Basak, Grzegorz W; Buchbinder, David; DeFilipp, Zachariah; Grkovic, Lana Desnica; ... (2022). Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Bone marrow transplantation, 57(7), pp. 1150-1163. Springer Nature 10.1038/s41409-022-01591-z

Phelan, Rachel; Im, Annie; Hunter, Rebecca L; Inamoto, Yoshihiro; Lupo-Stanghellini, Maria Teresa; Rovó, Alicia; Badawy, Sherif M; Burns, Linda; Eissa, Hesham; Murthy, Hemant S; Prasad, Pinki; Sharma, Akshay; Suelzer, Elizabeth; Agrawal, Vaibhav; Aljurf, Mahmoud; Baker, Karen; Basak, Grzegorz W; Buchbinder, David; DeFilipp, Zachariah; Grkovic, Lana Desnica; ... (2022). Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Transplantation and cellular therapy, 28(6), 335.e1-335.e17. Elsevier 10.1016/j.jtct.2021.10.013

Heidemeier, Anke; Thurner, Annette; Metz, Corona; Pabst, Thomas; Heidemeier, Heike; Rasche, Leo; Kortüm, K Martin; Einsele, Hermann; Grimm, Robert; Weiland, Elisabeth; Bley, Thorsten Alexander (2022). Whole-Body MRI with an Ultrahigh b-Value of 2000 s/mm2 Improves the Specificity of Diffusion-Weighted Imaging in Patients with Plasma Cell Dyscrasias. Academic radiology, 29(1), e1-e8. Elsevier 10.1016/j.acra.2020.09.016

Wörmann, Bernhard; Bokemeyer, Carsten; Burmeister, Thomas; Köhne, Claus-Henning; Schwab, Matthias; Arnold, Dirk; Blohmer, Jens-Uwe; Borner, Markus; Brucker, Sara; Cascorbi, Ingolf; Decker, Thomas; de Wit, Maike; Dietz, Andreas; Einsele, Hermann; Eisterer, Wolfgang; Folprecht, Gunnar; Hilbe, Wolfgang; Hoffmann, Jürgen; Knauf, Wolfgang; Kunzmann, Volker; ... (2020). Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper. Oncology research and treatment, 43(11), pp. 628-636. Karger 10.1159/000510258

Saussele, Susanne; Hehlmann, Rüdiger; Fabarius, Alice; Jeromin, Sabine; Proetel, Ulrike; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Einsele, Hermann; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F; Oppliger Leibundgut, Elisabeth; Heim, Dominik; Krause, Stefan W; Hofmann, Wolf-Karsten; Hasford, Joerg; ... (2018). Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV. Leukemia, 32(5), pp. 1222-1228. Nature Publishing Group 10.1038/s41375-018-0055-7

Hanfstein, Benjamin; Lauseker, Michael; Hehlmann, Rüdiger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fabarius, Alice; Proetel, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Krause, Stefan W; Schubert, Jörg; Einsele, Hermann; Hänel, Mathias; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; ... (2014). Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib. Haematologica - the hematology journal, 99(9), pp. 1441-1447. Ferrata-Storti Foundation 10.3324/haematol.2013.096537

Proetel, Ulrike; Pletsch, Nadine; Lauseker, Michael; Müller, Martin C; Hanfstein, Benjamin; Krause, Stefan W; Kalmanti, Lida; Schreiber, Annette; Heim, Dominik; Baerlocher, Gabriela M.; Hofmann, Wolf-Karsten; Lange, Elisabeth; Einsele, Hermann; Wernli, Martin; Kremers, Stephan; Schlag, Rudolf; Müller, Lothar; Hänel, Mathias; Link, Hartmut; Hertenstein, Bernd; ... (2014). Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV. Annals of hematology, 93(7), pp. 1167-1176. Springer 10.1007/s00277-014-2041-0

Hehlmann, Rüdiger; Müller, Martin C; Lauseker, Michael; Hanfstein, Benjamin; Fabarius, Alice; Schreiber, Annette; Proetel, Ulrike; Pletsch, Nadine; Pfirrmann, Markus; Haferlach, Claudia; Schnittger, Susanne; Einsele, Hermann; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F; ... (2014). Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV. Journal of clinical oncology, 32(5), pp. 415-423. American Society of Clinical Oncology 10.1200/JCO.2013.49.9020

Fabarius, Alice; Leitner, Armin; Hochhaus, Andreas; Müller, Martin C; Hanfstein, Benjamin; Haferlach, Claudia; Göhring, Gudrun; Schlegelberger, Brigitte; Jotterand, Martine; Reiter, Andreas; Jung-Munkwitz, Susanne; Proetel, Ulrike; Schwaab, Juliana; Hofmann, Wolf-Karsten; Schubert, Jörg; Einsele, Hermann; Ho, Anthony D; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; ... (2011). Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood, 118(26), pp. 6760-8. Washington, D.C.: American Society of Hematology 10.1182/blood-2011-08-373902

This list was generated on Thu Mar 28 19:18:00 2024 CET.
Provide Feedback